DR. BART DEVOS
ActiveSummary
DR. BART DEVOS has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €565,050 and a net result of €175,157. Equity is growing by ~15.9% per year across the filed fiscal years. The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Highest result since 2019net €175,157 ▲144%
Operating result €247,137, net result €175,157, both a record.
30-06
Financial
Equity above €500,000Eq €565,050 ▲33.4%
5 profitable years in a row build equity to €565,050.
31-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Liquidity quadruplescurrent ratio 26.47
Current ratio from 7.44 to 26.47; short-term debt falls from €50,546 to €13,224.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
15-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 15 days late
2021
30-06
Financial
Back to profitnet €57,420
Net result €57,420 after one loss-making year.
16-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 16 days late
2020
30-06
Financial
Weakest financial yearnet -€2,155
Net result drops to -€2,155, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
03-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
04-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
06-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.